120 likes | 132 Views
Uptake of HPV Vaccination Among Males: Couples Study. 141 st APHA Annual Meeting November 2013 Tom Collins and Richard A. Crosby, PhD University of Kentucky College of Public Health Department of Health Behavior. An Equal Opportunity University. Presenter Disclosures.
E N D
Uptake of HPV Vaccination Among Males: Couples Study 141st APHA Annual MeetingNovember 2013 Tom Collins and Richard A. Crosby, PhD University of Kentucky College of Public Health Department of Health Behavior An Equal Opportunity University
Presenter Disclosures Richard A. Crosby, PhD (1) The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months: Dr. Crosby served as a paid consultant for Merck Pharmaceuticals in 2012. Dr. Crosby is also a co-investigator on an investigator-initiated research project awarded to the University of Kentucky (E. Cohen, PI; MISP# 50154, 2013-2015) by Merck Pharmaceuticals. An Equal Opportunity University
Funding Source This presentation was supported by Cooperative Agreement Number 1U48DP001932-01 from the Centers for Disease Control and Prevention (CDC). The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the official position of the CDC. An Equal Opportunity University
UK Rural Cancer Prevention Center The Rural Cancer Prevention Center (RCPC) is a planned collaboration of community members, public health professionals, and researchers designed to reduce the health disparities associated with cervical, breast, and colorectalcancer among residents of the Kentucky River Health District in Appalachian Kentucky. An Equal Opportunity University
HPV and Men Cancers affecting men linked to Human Papillomavirus (HPV): Penile cancers (35%) Anal cancers (95%)* Oropharyngeal cancers(60-70%)* *Both men and women An Equal Opportunity University
Vaccine Recommendations ACIP recommends vaccination for males aged 9-26. Gardasil protects males against HPV types 16 and18 (associated with anal, penile, and oropharangeal cancers) Gardasil protects against HPV types 6 and 11 (associated with genital warts). An Equal Opportunity University
Vaccine Uptake and Intent Approximately 21% of boys aged 13-17 have received at least one dose. Only 2.1% of adult males aged 19-26 have received at least one dose. Intent to receive the vaccine is relatively high among adult males. An Equal Opportunity University
Purpose and Methods Pilot investigation to determine what would motivate young men (including relationship status with a female) to receive dose one of the HPV vaccine. Inclusion criteria 18-26 year old males. Report a current relationship with a female enrolled in a previous study concerning HPV vaccination. 32 males enrolled, received dose one of the vaccine and completed a questionnaire assessing motivations for vaccination) An Equal Opportunity University
ResultsParticipant Characteristics/HPV Motives An Equal Opportunity University
ResultsParticipant Characteristics/Sexual Health An Equal Opportunity University
Findings Most men were knowledgeable about HPV causing genital warts (90.6%) and cervical cancer (93.8%). HPV knowledge concerning genital warts was significantly correlated with motivation for vaccination (p=.04). Future research should focus on men’s aversion to genital warts. An Equal Opportunity University
Questions? An Equal Opportunity University